• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Indian Contract Manufacturing - A Hot Opportunity Product Image

Indian Contract Manufacturing - A Hot Opportunity

  • Published: March 2011
  • Region: India
  • 65 Pages
  • RNCOS E-Services Private Limited

FEATURED COMPANIES

  • Jubilant Life Sciences
  • Wockhardt Ltd.
  • MORE

The global pharmaceutical contract manufacturing industry has registered strong growth during the past few years. Amongst many other countries adopting the model, India has emerged as a market leader in pharma outsourcing. Outsourcing of drugs manufacturing provides many advantages for the pharmaceutical companies, such as enhanced production capacity, easier access to a large number of destination countries, and low scale up cost. Contract manufacturing will help the pharmaceutical companies to meet with the growing demand for new drugs and improve their core competencies.

According to our new research report “Indian Contract Manufacturing - A Hot Opportunity”, the demand for contract manufacturing services in India has been consistently rising due to the increasing cost pressure on pharmaceutical companies. The recent global economic slowdown was also a major factor for the adoption of contract manufacturing model. Leading pharma companies in the market are also looking at this model as a means to expand into the bio-similars and generics segment. With the changing economic scenario and the pressure of reducing drugs manufacturing cost, Indian contract manufacturing READ MORE >

1. Analyst View

2. Research Methodology

3. Market Overview

4. Regional Outlook and Scope
4.1 Developed Regions
4.1.1 Gujarat
4.1.2 Maharashtra
4.1.3 Andhra Pradesh
4.1.4 West Bengal
4.2 Upcoming Regions
4.2.1 Assam
4.2.2 Himachal Pradesh
4.2.3 Orissa

5. Market Analysis
5.1 Market Trends and Drivers
5.1.1 More Focus on Quality Products and GMP Regulations
5.1.2 Supplementary Services in Pharma Outsourcing
5.1.3 Emergence of Bio Manufacturing
5.1.4 Collaboration: A Preferred Way of Market Penetration
5.2 Current Industry Issues
5.2.1 IP Issues
5.2.2 Quality Assurance Risk
5.2.3 Inefficient Project Handling and Delivery

6. Regulatory Environment

7. Competitive Analysis
7.1 Piramal Healthcare Limited
7.2 Dishman Pharmaceuticals and Chemicals Ltd.
7.3 Dr. Reddy's Laboratories Ltd.
7.4 Jubilant Life Sciences
7.5 Wockhardt Ltd.

List of Tables:

Table 4-1: Summary of Issued and Commissioned Pharmaceutical Projects in Gujarat
Table 4-2: Potential Manpower Availability in Gujarat (2009)
Table 4-3: Potential Manpower Availability in Maharashtra
Table 4-4: Potential Manpower Availability in Andhra Pradesh (2009)
Table 4-5: Potential Manpower Availability in West Bengal (2009)
Table 7-1: Piramal Healthcare Limited - Strengths & Weaknesses
Table 7-2: Dishman Pharmaceuticals and Chemicals Ltd - Strengths & Weaknesses
Table 7-3: Dr. Reddy's Laboratories Ltd. - Strengths & Weaknesses
Table 7-4: Jubilant Life Sciences Ltd - Strengths & Weaknesses
Table 7-5: Wockhardt - Strengths & Weaknesses

List of Figures:

Figure 3-1: Pharma Outsourcing Services Market (Billion US$), 2008-2013
Figure 3-2: Pharma Contract Manufacturing Market (Million US$), 2009-2013
Figure 4-1: Regional Distribution of Pharmaceutical Manufacturing Units (%), 2010
Figure 4-2: Distribution of Pharmaceutical Clusters
Figure 4-3: Distribution of WHO GMP Certified Manufacturing Units in Gujarat (%)
Figure 4-4: Share of Gujarat in US FDA Approved Companies (2010)
Figure 4-5: Distribution of Schedule ‘M' Compliant Pharmaceutical Manufacturing Units in Maharashtra (%), 2009
Figure 4-6: Share of Andhra Pradesh in Bulk Drugs Manufacturing
Figure 4-7: Share of Andhra Pradesh in Bulk Drugs Export

- Piramal Healthcare Limited
- Dishman Pharmaceuticals and Chemicals Ltd.
- Dr. Reddy's Laboratories Ltd.
- Jubilant Life Sciences
- Wockhardt Ltd.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos